For decades, NORD has pursued federal and state policies that will change the lives of Americans impacted by rare diseases for the better. NORD’s work can be viewed below. This page is updated daily to provide timely information. Please contact us if you have questions or need additional information.
NORD letter in support of Alabama House Bill 82, an act calling for prescriber communication with regard to biosimilars
Published: Feb 15, 2017
Tagged in: Biosimilars, Access to Affordable Medicines
NORD letter in support of New Mexico Senate Bill 180 and House Bill 260, acts calling for prescriber communication with regard to biosimilars
Published: Feb 17, 2017
Tagged in: Biosimilars, Access to Affordable Medicines
Coalition principles regarding the uptake of biosimilars
Published: Sep 1, 2019
Tagged in: Biosimilars, Access to Affordable Medicines
NORD letter in support of South Carolina Senate Bill 299 and South Carolina House Bill 3438
Published: Feb 3, 2017
Tagged in: Biosimilars, Access to Affordable Medicines
Coalition letter to Congress in support of a provision to increase the uptake of biosimilars
Published: Jul 3, 2019
Tagged in: Biosimilars, Access to Affordable Medicines
